Platelet activating factor
Platelet activating factor is a lipid of Glycerophospholipids (GP) class. Platelet activating factor is associated with abnormalities such as Atherosclerosis, Acute cholecystitis without calculus, Cholecystitis, Colitis and Cholecystitis, Acute. The involved functions are known as Cell Survival, Metabolic Inhibition, lipid oxidation, Apoptosis and Oxidation. Platelet activating factor often locates in soluble, Cellular Membrane, Smooth muscle (tissue), Intima and Tissue specimen. The associated genes with Platelet activating factor are apolipoprotein A-I Milano, Homologous Gene, TSPO gene, HBEGF gene and SLC33A1 gene. The related lipids are Hydroxycholesterols, Liposomes, 25-hydroxycholesterol, Lysophosphatidylcholines and Lipopolysaccharides. The related experimental models are Knock-out, Mouse Model and Transgenic Model.
Cross Reference
Introduction
To understand associated biological information of Platelet activating factor, we collected biological information of abnormalities, associated pathways, cellular/molecular locations, biological functions, related genes/proteins, lipids and common seen animal/experimental models with organized paragraphs from literatures.
What diseases are associated with Platelet activating factor?
Platelet activating factor is suspected in Ischemia, Pleurisy, Atherosclerosis, Inflammatory disorder, Retinal Diseases, Diabetes and other diseases in descending order of the highest number of associated sentences.
Related references are mostly published in these journals:
- J. Lipid Res. (5)
- Proc. Natl. Acad. Sci. U.S.A. (2)
- Am. J. Physiol. Gastrointest. Liver Physiol. (2)
- Others (26)
| Disease | Cross reference | Weighted score | Related literature |
|---|
Loading... please refresh the page if content is not showing up.
Possible diseases from mapped MeSH terms on references
We collected disease MeSH terms mapped to the references associated with Platelet activating factor
PubChem Associated disorders and diseases
What pathways are associated with Platelet activating factor
There are no associated biomedical information in the current reference collection.
PubChem Biomolecular Interactions and Pathways
Link to PubChem Biomolecular Interactions and PathwaysWhat cellular locations are associated with Platelet activating factor?
Visualization in cellular structure
Associated locations are in red color. Not associated locations are in black.
Related references are published most in these journals:
| Location | Cross reference | Weighted score | Related literatures |
|---|
Loading... please refresh the page if content is not showing up.
What functions are associated with Platelet activating factor?
Related references are published most in these journals:
| Function | Cross reference | Weighted score | Related literatures |
|---|
What lipids are associated with Platelet activating factor?
Related references are published most in these journals:
| Lipid concept | Cross reference | Weighted score | Related literatures |
|---|
Loading... please refresh the page if content is not showing up.
What genes are associated with Platelet activating factor?
Related references are published most in these journals:
| Gene | Cross reference | Weighted score | Related literatures |
|---|
What common seen animal models are associated with Platelet activating factor?
Knock-out
Knock-out are used in the study 'A cardioprotective role for platelet-activating factor through NOS-dependent S-nitrosylation.' (Leary PJ et al., 2008).
Mouse Model
Mouse Model are used in the study 'A regulatory role of LPCAT1 in the synthesis of inflammatory lipids, PAF and LPC, in the retina of diabetic mice.' (Cheng L et al., 2009).
Transgenic Model
Transgenic Model are used in the study 'Heterogeneity in the sn-1 carbon chain of platelet-activating factor glycerophospholipids determines pro- or anti-apoptotic signaling in primary neurons.' (Ryan SD et al., 2008).
Related references are published most in these journals:
| Model | Cross reference | Weighted score | Related literatures |
|---|
Loading... please refresh the page if content is not showing up.
NCBI Entrez Crosslinks
All references with Platelet activating factor
Download all related citations| Authors | Title | Published | Journal | PubMed Link |
|---|---|---|---|---|
| Li X and Luo H | [Advances in pharmacological study of Piper kadsura (Choisy) Ohwi]. | 2002 | Zhong Yao Cai | pmid:14748373 |
| Sibelius U et al. | Distinct pathways of lipopolysaccharide priming of human neutrophil respiratory burst: role of lipid mediator synthesis and sensitivity to interleukin-10. | 2002 | Crit. Care Med. | pmid:12394960 |
| Pawliczak R et al. | Oxidative stress induces arachidonate release from human lung cells through the epithelial growth factor receptor pathway. | 2002 | Am. J. Respir. Cell Mol. Biol. | pmid:12444032 |
| MacKinnon AC et al. | Sphingosine kinase: a point of convergence in the action of diverse neutrophil priming agents. | 2002 | J. Immunol. | pmid:12444147 |
| Marrache AM et al. | Proinflammatory gene induction by platelet-activating factor mediated via its cognate nuclear receptor. | 2002 | J. Immunol. | pmid:12444157 |
| Pacheco P et al. | Lipopolysaccharide-induced leukocyte lipid body formation in vivo: innate immunity elicited intracellular Loci involved in eicosanoid metabolism. | 2002 | J. Immunol. | pmid:12444160 |
| Abe Y et al. | Effect of a platelet-activating factor antagonist, E5880, on cerebrovasospasm following subarachnoid hemorrhage in a canine double-hemorrhage model. | 2002 | Eur. J. Pharmacol. | pmid:12445578 |
| Marathe GK et al. | Activation of vascular cells by PAF-like lipids in oxidized LDL. | 2002 | Vascul. Pharmacol. | pmid:12449015 |
| Lacombe J et al. | Antisense inhibition of Flk-1 by oligonucleotides composed of 2'-deoxy-2'-fluoro-beta-D-arabino- and 2'-deoxy-nucleosides. | 2002 | Can. J. Physiol. Pharmacol. | pmid:12450061 |
| Francescangeli E et al. | Activation of PAF-synthesizing enzymes in rat brain stem slices after LTP induction in the medial vestibular nuclei. | 2002 | Neurochem. Res. | pmid:12512951 |
| Barbuti A et al. | Block of the background K(+) channel TASK-1 contributes to arrhythmogenic effects of platelet-activating factor. | 2002 | Am. J. Physiol. Heart Circ. Physiol. | pmid:12003807 |
| Ryan KL et al. | Platelet-activating factor does not mediate circulatory failure induced by 35-GHz microwave heating. | 2002 | Methods Find Exp Clin Pharmacol | pmid:12168504 |
| Takizawa T et al. | Inhibition of protein kinases A and C demonstrates dual modes of response in human eosinophils stimulated with platelet-activating factor. | 2002 | J. Allergy Clin. Immunol. | pmid:12170264 |
| Sun Z et al. | Effective treatment of gut barrier dysfunction using an antioxidant, a PAF inhibitor, and monoclonal antibodies against the adhesion molecule PECAM-1. | 2002 | J. Surg. Res. | pmid:12121711 |
| Mayer K et al. | Omega-3 fatty acids suppress monocyte adhesion to human endothelial cells: role of endothelial PAF generation. | 2002 | Am. J. Physiol. Heart Circ. Physiol. | pmid:12124231 |
| Giorgi G et al. | Mass spectrometric characterization of substituted 2-thiazolin-4-one derivatives. | 2002 | J Mass Spectrom | pmid:12125004 |
| Kulikov VI and Muzya GI | Influence of platelet-activating factor, its cell analogs, and antagonist on the production of superoxide radicals by blood leukocytes of healthy and hypercholesterolemic individuals. | 2002 | Biochemistry Mosc. | pmid:12126473 |
| Leusch A et al. | Altered drug disposition of the platelet activating factor antagonist apafant in mdr1a knockout mice. | 2002 | Eur J Pharm Sci | pmid:12128165 |
| Megens AA et al. | Pharmacological profile of (2R-trans)-4-[1-[3,5-bis(trifluoromethyl)benzoyl]-2-(phenylmethyl)-4-piperidinyl]-N-(2,6-dimethylphenyl)-1-acetamide (S)-Hydroxybutanedioate (R116301), an orally and centrally active neurokinin-1 receptor antagonist. | 2002 | J. Pharmacol. Exp. Ther. | pmid:12130734 |
| Kolaczkowska E et al. | Early vascular permeability in murine experimental peritonitis is co-mediated by resident peritoneal macrophages and mast cells: crucial involvement of macrophage-derived cysteinyl-leukotrienes. | 2002 | Inflammation | pmid:11989789 |
| Ahamed J and Ali H | Distinct roles of receptor phosphorylation, G protein usage, and mitogen-activated protein kinase activation on platelet activating factor-induced leukotriene C(4) generation and chemokine production. | 2002 | J. Biol. Chem. | pmid:11934880 |
| Akisu M et al. | The effect of dietary supplementation with n-3 polyunsaturated fatty acids on the generation of platelet-activating factor and leukotriene B4 in hypoxic-ischemic brain in young mice. | 2002 | Prostaglandins Leukot. Essent. Fatty Acids | pmid:12468264 |
| Castellvi J et al. | Effect of the platelet-activating factor antagonist BN-52021 on liver preservation (4 degrees): experimental study in isolated reperfused rat liver model. | 2002 | Transplant. Proc. | pmid:11959181 |
| Wang LS et al. | Effects of platelet activating factor, butyrate and interleukin-6 on cyclooxygenase-2 expression in human esophageal cancer cells. | 2002 | Scand. J. Gastroenterol. | pmid:11989839 |
| Börjesson A et al. | Early treatment with lexipafant, a platelet-activating factor-receptor antagonist, is not sufficient to prevent pulmonary endothelial damage after intestinal ischaemia and reperfusion in rats. | 2002 | Dig Liver Dis | pmid:11990391 |
| Borgquist JD et al. | Adhesion to extracellular matrix proteins modulates bovine neutrophil responses to inflammatory mediators. | 2002 | J. Leukoc. Biol. | pmid:11994500 |
| Kalkanci A et al. | The role of tumour necrosis factor-alpha (TNF-alpha) and platelet-activating factor (PAF) interaction on murine candidosis. | 2002 | Mycoses | pmid:12000505 |
| Bernatchez PN et al. | Relative effects of VEGF-A and VEGF-C on endothelial cell proliferation, migration and PAF synthesis: Role of neuropilin-1. | 2002 | J. Cell. Biochem. | pmid:11968003 |
| Hostettler ME et al. | Platelet-activating factor induces cell death in cultured astrocytes and oligodendrocytes: involvement of caspase-3. | 2002 | Glia | pmid:11968060 |
| Boisfer E et al. | Antioxidant properties of HDL in transgenic mice overexpressing human apolipoprotein A-II. | 2002 | J. Lipid Res. | pmid:11971944 |
| Yoshida H et al. | Platelet-activating factor enhances the expression of vascular endothelial growth factor in normal human astrocytes. | 2002 | Brain Res. | pmid:12106666 |
| Jaracz S et al. | Ginkgolides: selective acetylations, translactonization, and biological evaluation. | 2002 | J. Org. Chem. | pmid:12076171 |
| Downing SJ et al. | Effect of inflammatory mediators on the physiology of the human Fallopian tube. | 2002 | Hum Fertil (Camb) | pmid:12082208 |
| Honda Z et al. | Platelet-activating factor receptor. | 2002 | J. Biochem. | pmid:12038971 |
| Lloberas N et al. | Postischemic renal oxidative stress induces inflammatory response through PAF and oxidized phospholipids. Prevention by antioxidant treatment. | 2002 | FASEB J. | pmid:12039876 |
| Iatrou C et al. | Is platelet-activating factor produced during hemodialysis with AN-69 polyacrylonitrile membrane? | 2002 | Nephron | pmid:12021524 |
| Acuña AA et al. | Fluticasone propionate attenuates platelet-activating factor-induced gas exchange defects in mild asthma. | 2002 | Eur. Respir. J. | pmid:12030727 |
| Steel HC et al. | Platelet-activating factor and lyso-PAF possess direct antimicrobial properties in vitro. | 2002 | APMIS | pmid:12064871 |
| Haynes J and Obiako B | Activated polymorphonuclear cells increase sickle red blood cell retention in lung: role of phospholipids. | 2002 | Am. J. Physiol. Heart Circ. Physiol. | pmid:11748055 |
| Bussolati B et al. | Expression of CD154 on renal cell carcinomas and effect on cell proliferation, motility and platelet-activating factor synthesis. | 2002 | Int. J. Cancer | pmid:12209602 |
| Cadwallader KA et al. | Regulation of phosphatidylinositol 3-kinase activity and phosphatidylinositol 3,4,5-trisphosphate accumulation by neutrophil priming agents. | 2002 | J. Immunol. | pmid:12218155 |
| Bussolati B et al. | Nitric oxide/platelet activating factor cross-talk in mesangial cells modulates the interaction with leukocytes. | 2002 | Kidney Int. | pmid:12234302 |
| Weyrich AS et al. | Platelets, endothelial cells, inflammatory chemokines, and restenosis: complex signaling in the vascular play book. | 2002 | Circulation | pmid:12234942 |
| Han SJ et al. | Molecular mechanisms for lipopolysaccharide-induced biphasic activation of nuclear factor-kappa B (NF-kappa B). | 2002 | J. Biol. Chem. | pmid:12235132 |
| Akai T et al. | Modulation of tissue-type plasminogen activator expression by platelet activating factor in human glioma cells. | 2002 | J. Neurooncol. | pmid:12241114 |
| Ibe BO et al. | Metabolism of platelet activating factor by intrapulmonary vascular smooth muscle cells. Effect of oxygen on phospholipase A2 protein expression and activities of acetyl-CoA acetyltransferase and cholinephosphotransferase. | 2002 | Mol. Genet. Metab. | pmid:12409272 |
| Childs EW et al. | In vivo visualization of reactive oxidants and leukocyte-endothelial adherence following hemorrhagic shock. | 2002 | Shock | pmid:12412620 |
| Sakai H et al. | E3040 sulphate, a novel thromboxane synthase inhibitor, blocks the Cl- secretion induced by platelet-activating factor in isolated rat colon. | 2002 | Br. J. Pharmacol. | pmid:12023941 |
| Royal SJ et al. | Laminar disorganisation of mitral cells in the olfactory bulb does not affect topographic targeting of primary olfactory axons. | 2002 | Brain Res. | pmid:11911856 |
| Ko HM et al. | Nuclear factor kappaB dependency of platelet-activating factor-induced angiogenesis. | 2002 | Cancer Res. | pmid:11912159 |
| Ishiguro K et al. | Bisxanthones from Hypericum japonicum: inhibitors of PAF-induced hypotension. | 2002 | Planta Med. | pmid:11914965 |
| Barabé F et al. | Cholesterol-modulating agents selectively inhibit calcium influx induced by chemoattractants in human neutrophils. | 2002 | J. Biol. Chem. | pmid:11839753 |
| Mio T et al. | Lysophosphatidic acid augments fibroblast-mediated contraction of released collagen gels. | 2002 | J. Lab. Clin. Med. | pmid:11873241 |
| Klein A et al. | Platelet-activating factor drives eotaxin production in an allergic pleurisy in mice. | 2002 | Br. J. Pharmacol. | pmid:11877329 |
| Bulger EM et al. | The macrophage response to endotoxin requires platelet activating factor. | 2002 | Shock | pmid:11900334 |
| Talvani A et al. | Leukotriene B(4) induces nitric oxide synthesis in Trypanosoma cruzi-infected murine macrophages and mediates resistance to infection. | 2002 | Infect. Immun. | pmid:12117933 |
| Fonteh AN | Differential effects of arachidonoyl trifluoromethyl ketone on arachidonic acid release and lipid mediator biosynthesis by human neutrophils. Evidence for different arachidonate pools. | 2002 | Eur. J. Biochem. | pmid:12153573 |
| Chmiel B | [The influence of select pathophysiologic factors of acute pancreatitis on erythrocytes' deformability examined in vitro]. | 2002 | Wiad. Lek. | pmid:12715347 |
| Furukawa M et al. | Presence of platelet-activating factor in nasal polyps and eosinophils. | 2002 | Acta Otolaryngol. | pmid:12542208 |
| McKenna DJ et al. | Efficacy, safety, and use of ginkgo biloba in clinical and preclinical applications. | 2001 Sep-Oct | Altern Ther Health Med | pmid:11565403 |
| de Souza LJ et al. | Effect of platelet-activating factor antagonists (BN-52021, WEB-2170, and BB-882) on bacterial translocation in acute pancreatitis. | 2001 Jul-Aug | J. Gastrointest. Surg. | pmid:11985976 |
| Coker A et al. | Is mannitol effective against platelet-activating factor (PAF)-induced liver damage in obstructive jaundice? | 2001 Jul-Aug | Hepatogastroenterology | pmid:11490817 |
| Dery RE et al. | Inhibition of allergic inflammation by C-terminal peptides of the prohormone submandibular rat 1 (SMR-1). | 2001 Jan-Mar | Int. Arch. Allergy Immunol. | pmid:11306968 |
| Iwazaki S et al. | FR128998 ameliorates liver injury in extended liver resection with ischemia in dogs. | 2001 Jan-Feb | Hepatogastroenterology | pmid:11268964 |
| Magai RM and Shukla SD | Metabolic fate of [14C]-ethanol into endothelial cell phospholipids including platelet-activating factor, sphingomyelin and phosphatidylethanol. | 2001 Jan-Feb | J. Biomed. Sci. | pmid:11173988 |
| Denizot Y et al. | Is there a role of platelet-activating factor in human lung cancer? | 2001 Aug-Sep | Lung Cancer | pmid:11551414 |
| Jolly S et al. | Effect of intravenous platelet-activating factor on bovine pulmonary mast cells. | 2001 Aug-Oct | J. Comp. Pathol. | pmid:11578122 |
| Marathe GK et al. | Oxidized LDL contains inflammatory PAF-like phospholipids. | 2001 Apr-May | Trends Cardiovasc. Med. | pmid:11686003 |
| Lee T et al. | Differential regulation of three catalytic activities of platelet-activating factor (PAF)-dependent transacetylase. | 2001 | Arch. Biochem. Biophys. | pmid:11368182 |
| Iwase M et al. | Cardiac functional and structural alterations induced by endotoxin in rats: importance of platelet-activating factor. | 2001 | Crit. Care Med. | pmid:11373429 |
| Jehle R et al. | Platelet-activating factor (PAF)-acetylhydrolase and PAF-like compounds in the lung: effects of hyperoxia. | 2001 | Biochim. Biophys. Acta | pmid:11420174 |
| Kulikov VI and Muzya GI | Inhibition of human platelet aggregation by amides and ester of salicylic acid with platelet-activating factor analogs. | 2001 | Biochemistry Mosc. | pmid:11421815 |
| Virchow JC et al. | Effect of a specific cysteinyl leukotriene-receptor 1-antagonist (montelukast) on the transmigration of eosinophils across human umbilical vein endothelial cells. | 2001 | Clin. Exp. Allergy | pmid:11422147 |
| Ferland C et al. | Eotaxin promotes eosinophil transmigration via the activation of the plasminogen-plasmin system. | 2001 | J. Leukoc. Biol. | pmid:11358986 |
| McManus LM et al. | Agonist-dependent failure of neutrophil function in diabetes correlates with extent of hyperglycemia. | 2001 | J. Leukoc. Biol. | pmid:11527989 |
| Qian C et al. | Anti-inflammatory activities of LDP-392, a dual PAF receptor antagonist and 5-lipoxygenase inhibitor. | 2001 | Pharmacol. Res. | pmid:11529688 |
| Persidsky Y et al. | Reduction in glial immunity and neuropathology by a PAF antagonist and an MMP and TNFalpha inhibitor in SCID mice with HIV-1 encephalitis. | 2001 | J. Neuroimmunol. | pmid:11240016 |
| Bachert C | Decongestant efficacy of desloratadine in patients with seasonal allergic rhinitis. | 2001 | Allergy | pmid:11243500 |
| Roudebush WE et al. | Impact of blood serum insulin-like growth factor I on platelet-activating factor in bull spermatozoa. | 2001 | Domest. Anim. Endocrinol. | pmid:11164329 |
| Giménez R and Aguilar J | Cytidine (5') diphosphocholine-induced decrease in cerebral platelet activating factor is due to inactivation of its synthesizing enzyme cholinephosphotransferase in aged rats. | 2001 | Neurosci. Lett. | pmid:11165772 |
| Goudevenos J et al. | Platelet-associated and secreted PAF-acetylhydrolase activity in patients with stable angina: sequential changes of the enzyme activity after angioplasty. | 2001 | Eur. J. Clin. Invest. | pmid:11168434 |
| Galimi F et al. | Hepatocyte growth factor is a regulator of monocyte-macrophage function. | 2001 | J. Immunol. | pmid:11145707 |
| Mariano F et al. | Hemofiltration reduces the serum priming activity on neutrophil chemiluminescence in septic patients. | 2001 | Kidney Int. | pmid:11576379 |
| Fazal N et al. | PAF receptor antagonist modulates neutrophil responses with thermal injury in vivo. | 2001 | Am. J. Physiol., Cell Physiol. | pmid:11546669 |
| Beales IL | Effect of platelet-activating factor on gastrin release from cultured rabbit G-cells. | 2001 | Dig. Dis. Sci. | pmid:11284466 |
| McHowat J et al. | Endothelial cell PAF synthesis following thrombin stimulation utilizes Ca(2+)-independent phospholipase A(2). | 2001 | Biochemistry | pmid:11732912 |
| Sirolli V et al. | Platelet activation and platelet-erythrocyte aggregates in end-stage renal disease patients on hemodialysis. | 2001 | Thromb. Haemost. | pmid:11583316 |
| Johnson CD et al. | Double blind, randomised, placebo controlled study of a platelet activating factor antagonist, lexipafant, in the treatment and prevention of organ failure in predicted severe acute pancreatitis. | 2001 | Gut | pmid:11115824 |
| Thom SR et al. | Roles for platelet-activating factor and *NO-derived oxidants causing neutrophil adherence after CO poisoning. | 2001 | Am. J. Physiol. Heart Circ. Physiol. | pmid:11454599 |
| Grosman N | Similar effects of ether phospholipids, PAF and lyso-PAF on the Ca(2+)-ATPase activity of rat brain synaptosomes and leukocyte membranes. | 2001 | Int. Immunopharmacol. | pmid:11460312 |
| Marathe GK et al. | Lysophosphatidylcholine and lyso-PAF display PAF-like activity derived from contaminating phospholipids. | 2001 | J. Lipid Res. | pmid:11518762 |
| Smith DG et al. | Quinolinic acid is produced by macrophages stimulated by platelet activating factor, Nef and Tat. | 2001 | J. Neurovirol. | pmid:11519483 |
| Hoenstein R et al. | Interleukin-2 activates human peripheral blood eosinophils. | 2001 | Cell. Immunol. | pmid:11520078 |
| Burke JR et al. | BMS-229724 is a tight-binding inhibitor of cytosolic phospholipase A2 that acts at the lipid/water interface and possesses anti-inflammatory activity in skin inflammation models. | 2001 | J. Pharmacol. Exp. Ther. | pmid:11408565 |
| Richardson RM et al. | RGS4 inhibits platelet-activating factor receptor phosphorylation and cellular responses. | 2001 | Biochemistry | pmid:11297424 |
| Kuijpers TW et al. | The impact of platelet-activating factor (PAF)-like mediators on the functional activity of neutrophils: anti-inflammatory effects of human PAF-acetylhydrolase. | 2001 | Clin. Exp. Immunol. | pmid:11298128 |
| Teeling JL et al. | Intravenous immunoglobulin preparations induce mild activation of neutrophils in vivo via triggering of macrophages--studies in a rat model. | 2001 | Br. J. Haematol. | pmid:11298603 |
| Teather LA et al. | Differential interaction of platelet-activating factor and NMDA receptor function in hippocampal and dorsal striatal memory processes. | 2001 | Neurobiol Learn Mem | pmid:11300737 |
| Aiboshi J et al. | Blood transfusion and the two-insult model of post-injury multiple organ failure. | 2001 | Shock | pmid:11303730 |
| Berdyshev EV et al. | Activation of PAF receptors results in enhanced synthesis of 2-arachidonoylglycerol (2-AG) in immune cells. | 2001 | FASEB J. | pmid:11641243 |